Notice of allowance of patent in Canada

AI SummaryClose X

Fusion Antibodies plc has received a notice of allowance from the Canadian Intellectual Property Office for its patent application no. 3,115,150, titled "Antibody Library and Method," which covers two antibody families and their design methodology. This patent, once granted, is expected to complement the company's "Opti" designed antibody libraries used for discovery, affinity maturation, and sequence optimisation. Fusion is also pursuing similar patent applications in Europe and China for its OptiMAL® Library. The notice of allowance signifies patentability, with the formal grant anticipated upon completion of administrative requirements and payment of fees.

Disclaimer*

UK 100

Latest directors dealings